(Q35043762)

6 August 2017

1 reference

title

Resistance in the anti-angiogenic era: nay-saying or a word of caution? (English)

1 reference

6 August 2017

angiogenesis inhibitor

1 reference

2

Kathy D Miller

1 reference

6 August 2017

3

George W Sledge

1 reference

6 August 2017

Christopher J Sweeney

series ordinal

1

1 reference

PubMed ID

12524207

6 August 2017

language of work or name

1 reference

1 January 2003

1 reference

Trends in Molecular Medicine

6 August 2017

1 reference

6 August 2017

9

1 reference

6 August 2017

24-29

1 reference

6 August 2017

1

1 reference

What Is the Evidence That Tumors Are Angiogenesis Dependent?

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

A cancer therapy resistant to resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Redefining the target: chemotherapeutics as antiangiogenics

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Expression of basic fibroblast growth factor protein and its down-regulation by interferons in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Negative regulation of cytokine signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Signaling mechanisms mediating vascular protective actions of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Oncogenes and angiogenesis: signaling three-dimensional tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

The role of vascular endothelial growth factor in pathological angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Expression of the multidrug-resistance P-glycoprotein (Pgp, MDR-1) by endothelial cells of the neovasculature in central nervous system tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Genes expressed in human tumor endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Effect of p53 status on tumor response to antiangiogenic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Role of the tumor microenvironment in mediating response to anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Vascular morphogenesis and remodeling in a human tumor xenograft: blood vessel formation and growth after ovariectomy and tumor implantation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Vasculogenic mimicry and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2900007-2

7 January 2021

10.1016/S1471-4914(02)00007-2

Identifiers

DOI

1 reference

release_fhb7y5ww7rfqvh4xopgf4ogccy

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fhb7y5ww7rfqvh4xopgf4ogccy

24 November 2022

mapped directly with Wikidata item

PubMed ID

12524207

1 reference

PubMed ID

12524207